The store will not work correctly when cookies are disabled.
2-(3a,8b-dihydrobenzofuro[3,2-d]thiazol-2-yl)indane-1,3-dione
ID: ALA4514228
PubChem CID: 118545071
Max Phase: Preclinical
Molecular Formula: C18H11NO3S
Molecular Weight: 321.36
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1c2ccccc2C(=O)C1C1=NC2c3ccccc3OC2S1
Standard InChI: InChI=1S/C18H11NO3S/c20-15-9-5-1-2-6-10(9)16(21)13(15)17-19-14-11-7-3-4-8-12(11)22-18(14)23-17/h1-8,13-14,18H
Standard InChI Key: ZPIPRZGWVKZFAV-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 27 0 0 0 0 0 0 0 0999 V2000
12.5124 -22.6136 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2162 -22.2064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9204 -22.6172 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9204 -23.4325 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2188 -23.8391 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5124 -23.4336 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6964 -23.6739 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1838 -23.0120 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7142 -22.3656 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9262 -21.5781 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.9987 -23.0120 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4162 -22.2879 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
17.2460 -22.4788 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3262 -23.2876 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5571 -23.6255 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.1229 -23.4528 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5402 -22.7467 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0143 -22.1518 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.3572 -22.7562 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7608 -23.4712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3446 -24.1736 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5247 -24.1720 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9043 -24.4614 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
6 5 2 0
1 6 1 0
4 7 1 0
7 8 1 0
9 8 1 0
3 9 1 0
9 10 2 0
11 8 1 0
11 12 1 0
12 13 1 0
13 14 1 0
15 14 1 0
11 15 2 0
14 16 1 0
16 17 2 0
18 17 1 0
13 18 1 0
17 19 1 0
20 19 2 0
21 20 1 0
22 21 2 0
16 22 1 0
7 23 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 321.36 | Molecular Weight (Monoisotopic): 321.0460 | AlogP: 3.29 | #Rotatable Bonds: 1 |
Polar Surface Area: 55.73 | Molecular Species: NEUTRAL | HBA: 5 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.27 | CX Basic pKa: 1.18 | CX LogP: 3.30 | CX LogD: 3.24 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.76 | Np Likeness Score: 0.07 |
References
1. (2017) Arf6 inhibitors and methods of synthesis and use thereof, |